Fondazione Matilde Tettamanti Menotti De Marchi Onlus clinical trials
Fondazione Matilde Tettamanti Menotti De Marchi Onlus is the lead sponsor of 3 current clinical trials in our Italy register. 3 are recruiting patients now. The most common phase is Phase 1/2. The most-studied condition is AML (Acute Myeloid Leukemia).
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Fondazione Matilde Tettamanti Menotti De Marchi Onlus
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults
NCT07877610 · ClinicalTrials.gov ↗ · AML (Acute Myeloid Leukemia), BPDCN
|
Phase 1/2 | Recruiting | 2026-10 | Italy |
|
Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
NCT07899840 · ClinicalTrials.gov ↗ · Acute Lymphobkastic Leukemia
|
Observational | Recruiting | 2025-02 | Italy |
|
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
NCT05869279 · ClinicalTrials.gov ↗ · B-cell NHL, CLL
|
Phase 1/2 | Recruiting | 2023-12 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Fondazione Matilde Tettamanti Menotti De Marchi Onlus trials
5 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 3 | 3 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in AML (Acute Myeloid Leukemia)
| Sponsor | Trials |
|---|---|
| The Second Affiliated Hospital of Kunming Medical University | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Fondazione Matilde Tettamanti Menotti De Marchi Onlus trials
How many clinical trials does Fondazione Matilde Tettamanti Menotti De Marchi Onlus sponsor?
Fondazione Matilde Tettamanti Menotti De Marchi Onlus is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 29 October 2026. Completed and withdrawn studies are not counted.
Are Fondazione Matilde Tettamanti Menotti De Marchi Onlus trials recruiting?
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 29 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.